Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
about
AtherosclerosisThe CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the futureCD40 in coronary artery disease: a matter of macrophages?The role of platelets in the recruitment of leukocytes during vascular diseaseThe role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosisThe influence of innate and adaptive immune responses on atherosclerosisT cell costimulatory and coinhibitory pathways in vascular inflammatory diseasesAutoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesionsIntranasal delivery of E-selectin reduces atherosclerosis in ApoE-/- miceDysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice.CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.Correlation between near-infrared Raman spectroscopy and the histopathological analysis of atherosclerosis in human coronary arteries.Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-CoDeR phage display library.Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profileEffects of clopidogrel therapy on oxidative stress, inflammation, vascular function, and progenitor cells in stable coronary artery disease.CD40L and Its Receptors in Atherothrombosis-An UpdateTumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans.CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies.Microvascular thrombosis and CD40/CD40L signaling.Inflammatory bio-markers and cardiovascular risk prediction.Stabilization of atherosclerotic plaques: new mechanisms and clinical targets.Beta3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice.Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype.Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients.Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand systemPlatelets in inflammation and atherogenesis.Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis.Cardiovascular proteomics: past, present, and future.Cardiovascular disease, inflammation, and periodontal infection.T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice.miR-145 mediated the role of aspirin in resisting VSMCs proliferation and anti-inflammation through CD40Autoimmunity in atherosclerosis: a protective response losing control?CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammationT-cell costimulation and coinhibition in atherosclerosis.Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.
P2860
Q24644573-BA357D09-915C-4A17-9914-ED4572C7CA4BQ24673258-E126E3AE-6658-42C0-A001-7DD51E3556C4Q26752784-07D65B36-A7EC-4273-8A0C-23FAE7A749E0Q26801407-21C80BF0-2BE3-4B0E-8329-E98689647113Q26996707-894DC022-6910-4194-950D-1369552807A8Q27000370-31A6775E-754B-45F2-B608-B38AF595FBF8Q28396774-F19F23BD-8851-41EE-A880-650ACA75948BQ28710388-B799F2B7-934F-4AC5-B5A0-3AE19E5945C5Q28743431-63333AD2-9F4C-4D22-BCE5-B80F1DF87AC1Q30405805-4A47B7D8-347C-43B1-9A38-599348AF103FQ30441065-77F23DD0-DDFD-44B9-BC0E-9C9CC5487EAFQ30497499-95EF1C3D-D02A-4577-BAB7-2906D2D336E4Q30701029-8D686D2F-44C9-4011-B9C2-E484458D26D1Q31100421-52C7DD94-99F7-4BD7-AC2E-F330E367B295Q33183129-669A7608-BB1A-427D-AEBA-EA6C5946E935Q33635135-68C21A41-64F6-4728-9470-DC7ACC57C233Q33656103-945A3279-30F5-49BE-86D5-32EA119E3640Q33715270-36FB4590-CD9F-426D-9AC9-7AA501E1F02AQ33814059-B679CEB3-7410-4248-8EA9-47E6AF3CC14EQ33996260-246D331C-A7B5-4B95-A19A-43FE0D6968BDQ34193651-A1418429-C8F7-4FC4-B2E4-5EA5C533369CQ34630514-89097638-A047-4DBF-9ADD-ECF63F0B96F3Q34941391-5CCC4DD2-8067-4367-875B-49C1110160C5Q34986368-3D9ECF1D-ED16-493E-B1CB-1675861FB906Q35144122-78247E5D-A93B-4194-81AA-58E3780703BAQ35161070-01FCA46E-AD87-413B-9B1C-E05E5E1F21A1Q35795164-2D8EA0DC-7C99-4ED8-964C-A986604D93ACQ35824531-514FFA86-785C-4438-BC4D-F31492CA88F3Q35994774-1B984DA5-77FD-4C9D-8A3A-54FA5DD4C921Q36216095-4F7918DF-4880-4E1F-93E4-68C08B58ABDCQ36328825-55BE2454-F2D8-4CF4-845F-F493EC557D58Q36691050-DAAFB9D9-6A82-4716-AAEA-932D84F51C02Q36775610-1AA4C8EF-7E3D-499D-8362-939B34D1580EQ36809182-015D71D5-FFBF-4481-AA09-30D36A67C0C1Q36976746-A36A1AF2-09D3-4698-A36B-406C6C66815BQ37093868-D0965C5D-0DDC-4180-89C9-2666B2FAEB49Q37138017-94AFB0C7-A70B-452C-85C8-D63FCFD20654Q37138961-6941A50A-8512-4D20-A9A5-789F5873BCEEQ37143018-7D8DDA27-83C4-41E3-85C5-3E6CCD3D3535Q37300823-376E5025-9FA7-4680-88ED-C00A46914D0A
P2860
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
@ast
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
@en
type
label
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
@ast
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
@en
prefLabel
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
@ast
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
@en
P2093
P2860
P356
P1476
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
@en
P2093
P2860
P304
P356
10.1073/PNAS.97.13.7458
P407
P577
2000-06-01T00:00:00Z